Normal and pathological Tau proteins as factors for microtubule assembly

International Review of Cytology

Volumn 171, Issue , 1997, Pages 167-224

  Delacourte, André ^a   Buée, Luc ^a  

^a INSERM   (France)

Author keywords

Alzheimer's disease; Corticobasal degeneration; MAPs; Microtubules; Neurofibrillary degeneration; PHF; Phosphorylation; Pick disease; Tau proteins

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; PHOSPHATASE; PROTEIN KINASE; TAU PROTEIN; TUBULIN; UBIQUITIN;

AGING; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL ULTRASTRUCTURE; DOWN SYNDROME; GENE STRUCTURE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; MICROTUBULE; MICROTUBULE ASSEMBLY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSONISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; REVIEW;

EID: 0030905501     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)62588-7     Document Type: Review

References (268)

1. Aamodt, E. J., and Williams, R. C, Jr. (1984). Microtubule-associated proteins connect microtubules and neurofilaments in vitro. Biochemistry 23, 6023-6031.
2. Abe, H., Yagishita, S., and Amano, N. (1994). Unusual argyrophilic glial cells in progressive supranuclear palsy. Neiirodegeneration 3, 85-90.
3. Albert, M. S. (1978). Subcortical dementia. In "Alzheimer's Disease Senile, Dementia and Related Disorders, Aging" R. Katzman, R. D. Terry, and K. L. Bick, Eds., Vol. 7. Raven Press, New York.
4. Alonso, A. D., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1994). Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer's disease. Proc. Nail. Acad. Sei. USA 91, 5562-5566.
5. Andreadis, A., Brown, W. M., and Kosik, K. S. (1992). Structure and novel exons of the human-Tau gene. Biochemistry 31, 10626-10633.
6. Andreadis, A., Broderick, J. A., and Kosik, K. S. (1995). Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exon. Nucleic Acids Res. 23,3585-3593.
7. Andreadis, A., Wagner, B. K., Broderick, J. A., and Kosik, K. S. (1996). A tau promoter region without neuronal specificity. J. Netirochem. 66, 2257-2263.
8. Arendt, T., Holzer, M., Grossmann, A., Zedlick, D., and Bruckner, M. K. (1995). Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Acta Psychiatr. Scand. 68, 5-18.
9. Arnold, C. S., Cole, R. N., Johnson, G. V. W., and Hart, G. W. (1994). Tau is a glycoprotein. Soc. Neitrosci. Abstr. 20, 1035.
10. Askanas, V., Engel, W. K., Bilak, M., Alvarez, R. B., and Selkoe, D. J. (1994). Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am. J. Palhol. 144, 177-187.
11. Auer, I. A-, Schmidt, M. L., Lee, V. M. Y., Curry, B., Suzuki, K., Shin, R. W., Pentchev, P. G., Carstea, E. D., and Trojanowski, J. Q. (1995). Paired helical filament Tau (PHFtau) in Niemann-Pick type C disease is similar to PHFTau in Alzheimer's disease. Acta Neuropathol, 90, 547-551.
12. Baudier, J., and Cole, R. D (1987). Phosphorylation of Tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. BioL Chem. 262, 17577-17583.
13. Baum, L., Seger, R., Woodgett, J. R., Kawabata, S., Maruyama, K., Koyama, M., Silver, J., and Saitoh, T. (1995). Overexpressed Tau protein in cultured cells is phosphorylated without formation of PHF: Implication of phosphoprotein phosphatase involvement. Mol. Brain Res. 34, 1-17.
14. Baumann, K., Mandelkow, E. M., Biernat, J., et al. (1993). Abnormal Alzheimer-like phosphorylation of Tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEES Lett. 336,417-424.
15. Behar, L., Marx, R., Sadot, E., Barg, J., and Ginzburg, I. (1995). cis-acting signals and transacting proteins are involved in Tau mRNA targeting into neuntes of differentiating neuronal cells. Int. J. Dev. Neurosd. 13, 113-127.
16. Benzing, W. C., and Mufson, E. J. (1995). Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to Tau and PHF in Alzheimer's disease. Exp. Neural. 132, 162-171.
17. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E. M., and Mandelkow, E. (1993). Phosphorylation of ser(262) strongly reduces binding of Tau-protein to microtubules-Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153-163.
18. Binder, L. I., Frankfurter, A., and Rebhun, L. (1985). The distribution of Tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378.
19. Bons, N., Jallageas, V., Mestre-Frances, N., Silhol, S., Petter, A., and Delacourte, A. (1995). Microcebus murinus, a convenient laboratory animal model for the study of Alzheimer's disease. Alzheimer's Res. 1, 83-87.
20. Boucher, D., Larcher, J. C., Gros, F., and Denoulet, P. (1994). Polyglutamylation of tubulin as a progressive regulator of in vitro interaction between the microtubule-associated protein Tau and tubulin. Biochemistry 33, 12471-12477.
21. Bouras, C, Hof, P. R., Giannakopoulos, P., Michel, J. P., and Morrison, J. H. (1994). Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients - A quantitative evaluation of a one-year-autopsy population from a geriatric hospital. Cerebral Cortex 4, 138-150.
22. Boyne, L. J., Tessler, A., Murray, M., and Fischer, I. (1995). Distribution of Big Tau in the central nervous system of the adult and developing rat. J. Camp. Neural. 358, 279-293.
23. Braak, H., and Braak, E. (1988). Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol. Appl. Neural. 14, 39-43.
24. Braak, H., and Braak, E., Grundke-Iqbal, I., and Iqbal, K. (1988). Occurrence of neuropils threads in the senile human brain and in Alzheimer's disease. A 3rd location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosd. Lett. 65, 351-355.
25. Braak, H., and Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278.
26. Braak, H., Braak, E., and Strothjohann, M. (1994). Abnormally phosphorylated Tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosd. Lett. 171,1-4.
27. Brady, R. M., Zinkowski, R. P., and Binder, L. I. (1995). Presence of Tau in isolated nuclei from human brain. Neurobiol. Aging 16, 479-486.
28. Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., and Lee, V. M. Y. (1993). Abnormal Tau-phosphorylation at ser(396) in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10,1089-1099.
29. Brandt, R., Leger, J., and Lee, G. (1995). Interaction of Tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131,1327-1340.
30. Brion, J. P., Passareiro, H., Nunez, J., and Flament-Durand, J. (1985). Immunological detection of Tau protein in neurofibrillary tangles of Alzheimer's disease. Arch. Biol. 95, 229-235.
31. Brion, S., and Mikol, J. (1973). Recent findings in Pick's disease. Prog. Neuropathol. 2, 421.
32. Brun, A., Englund, B., Gustafson, L., Passant, U., Mann, D. M. A., Neary, D., and Snowden, J. S. (1994). Clinical and neuropathological criteria for frontotemporal dementia. J. Neural. Neitrosurg. Ps. 57, 416-418.
33. Buée, L., Hof, P. R., Rosenthal, R. E., Delacourte, A., and Fiskum, G. (1996). Tau proteins phosphorylation and proteolysis in a canine model of cerebral ischemia/reperfusion. Submitted for publication.
34. Buée-Scherrer, V., Buée, L., Vermersch, P., et al. (1994). Tau pathology in neurodegenerative disorders: Biochemical analysis. Soc. Neurosci. Abstr. 20,1647.
35. Buée-Scherrer, V., Buée, L., Hof, P. R., Leveugle, B., Gilles, C, Loerzel, A. J., Perl, D. P., and Delacourte, A. (1995). Neurofibrillary degeneration in amyotrophic lateral sclerosis/ parkinsonism-dementia complex of Guam-Immunochemical characterization of Tau proteins. Am. J. Pathol. 146, 924-932.
36. Buée-Scherrer, V., Condamines, O., Mourton-Gilles, C, Jakes, R., Goedert, M., Pau, B., and Delacourte, A. (1996a). AD2, a phosphorylation-dependent monoclonal antibody directed against Tau proteins found in Alzheimer's disease. Mol. Brain Res. 39, 79-88.
37. Buée-Scherrer, V., Hof, P. R., Buée, L., Leveugle, B., Vermersch, P., Perl, D. P., Olanow, C. W., and Delacourte, A. (1996b). Hyperphosphorylated Tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. 91, 351-359.
38. Buée-Scherrer, V., Buée, L., Perl, D. P., et al. (1996c). Pathological tau proteins in postencephalitic parkinsonism: Similarities and differences with Alzheimer's disease and other neurode-generative disorders. Submitted for publication.
39. Burgoyne, R. D. (1991). "The Neuronal Cytoskeleton," pp. 1-323. Wiley-Liss, New York.
40. Busciglio, J., Lorenzo, A., Yeh, J., and Yanker, B. A. (1995). beta Amyloid fibrils induce Tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
41. Butner, K. A., and Kirschner, M. W. (1991). Tau-protein binds to microtubules through a flexible array of distributed weak sites. J. Cell. Biol. 115, 717-730.
42. Buxton, J., Shelbourne, P., and Davies, J. (1992). Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547-548.
43. Caceres, A., and Kosik, K. S. (1990). Inhibition of neunte polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 343, 461-463.
44. Caceres, A., Potrebic, S., and Kosik, K. S. (1991). The effect of tau-antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. J. Neurosci. 11, 1515-1523.
45. Caillet-Boudin, M. L., and Delacourte, A. (1996). Phosphorylated Ser 422, a specific Alzheimer epitope, is expressed by SKNSH-SY5Y cells after okadaic acid. Neuroreport 8, in press.
46. Carlier, M. F., Simon, C., Cassoly, R., and Pradel, L. A. (1984). Interaction between microtubule-associated protein Tau and spectrin. Biochimie. 664,305-311.
47. Chapin, S. J., Lue, C. M., Yu, M. T., and Bulinski, J. C. (1995). Differential expression of alternatively spliced forms of MAP4: A repertoire of structurally different microtubulebinding domains. Biochemistry 34,2289-2301.
48. Chin, S. S. M., and Goldman, J. E. (1996). Glial inclusions in CNS degenerative diseases. J. Neuropathol. Exp. Neural. 55, 499-508.
49. Cohen, P., and Cohen, P. T. W. (1989). Protein phosphatases come of age. J. Biol. Chem. 264, 21435-21438.
50. Correas, I., Padilla, R., and Avila, J. (1990). The tubulin-binding sequence of brain microtubule-associated proteins, Tau and MAP2, is also involved in actin binding. Biochem. J. 269,61-64.
51. Cummings, J. L., and Benson, D. F. (1984). Subcortical dementia: review of an emerging concept. Arch. Neural. 41, 874-879.
52. Delacourte, A. (1994). Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomed. Pharmacother. 48,287-295.
53. Delacourte, A., and Défossez, A. (1986). Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neural. Sei. 76, 173-186.
54. Delacourte, A., Flament, S., Dibe, E. M., Hublau, P., Sablonniere, B., Hemon, B., Scherrer, V., and Défossez, A. (1990). Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol. 80,111-117.
55. Delacourte, A., Robitaille, Y., Sergeant, N., Buee, L., Hof, P. R., Wattez, A., Laroche-Cholette, A., Mathieu, J., Chagnon, P., and Gauvreau, D. (1996). Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neural. 55,159-168.
56. Dermott, J. B., Aamodt, S., and Aamodt, E. (1996) ptl-1, a gene whose products are homologous to the tau microtubule-associated proteins. Biochemistry 35, 9415-9423.
57. Dewar, D., and Dawson, D. (1995). Tau protein is altered by focal cerebral ischaemia in the rat: An immunohistochemical and immunoblotting study. Brain Res. 684, 70-78.
58. Dewar, D., Graham, D. I., Teasdale, G. M., and McCulloch, J. (1994). Cerebral ischemia induces alterations in Tau and ubiquitin proteins. Dementia 5,168-173.
59. Ditella, M. C, Feiguin, F., Carri, N., Kosik, K. S., and Caceres, A. (1996). Map-1B/Tau functional redundancy during laminin-enhanced axonal growth. J. Cell Sd. 109, 467-477.
60. Dong, D. L. Y., Xu, Z. S., Chevier, M. R., Cotter, R. J., Cleveland, D. W., and Hart, G. W. (1993). Glycosylation of mammalian neurofilaments-Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides-L and poIypeptides-M. J. Biol. Chem. 268, 16679-16687.
61. Dotti, C. G., and Banker, G. (1991). Intracellular organization of hippocampal neurons during the development of neuronal polarity. J. Cell. Sei. Suppl. 15, 75-84.
62. Dotti, C. G., Banker, G., and Binder, L. I. (1987). The expression and distribution of the microtubule-associated proteins Tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience 23,121-130.
63. Drewes, G., Lichtenbergkraag, B., Doring, F., Mandelkow, E. M., Biernat, J., and Gori, X. (1992). Mitogen activated protein (MAP) kinase transforms Tau-protein into an Alzheimer-like state. EMBO J. 11, 2131-2138.
64. Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmittulms, G., Meyer, H. E., Mandelkow, E. M., and Mandelkow, E. (1995). Microtubule-associated protein microtubule affinity-regulating kinase (p110(mark))-A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem. 270, 7679-7688.
65. Drubin, D. G., and Kirschner, M. W. (1986). Tau protein function in living cells. J. Cell. Biol. 103, 2738-2746.
66. Drubin, D. G., Kobayashi, S., Kellogg, D., and Kirschner, M. W. (1988). Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J. Cell Biol. 106, 1583-1591.
67. Dudek, S. M., and Johnson, G. V. W. (1995). Postnatal changes in Ser/Thr protein phosphatases and their association with microtubules. Dev. Brain Res. 90, 54-61.
68. Dupont-Wallois, L., Sautiere, P. E., Cocquerelle, C., Bailleul, B., Delacourte, A., and Caillet-Boudin, M. L. (1995). Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 357, 197-201.
69. Dustin, P. (1984). "Microtubules." Springer-Verlag, Berlin/New York.
70. Feany, M. B., and Dickson, D. W. (1995). Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am. J. Palhol. 146, 1388-1396.
71. Feany, M. B., Ksiezak-Reding, H., Liu, W. K., Vincent, I., Yen, S. H. C, and Dickson, D. W. (1995b). Epitope expression and hyperphosphorylation of Tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy. Acta Neuropathol. 90, 37-43.
72. Feany, M. B., Mattiace, L. A., and Dickson, D. W. (1996). Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 55, 53-67.
73. Ferreira, A., and Caceres, A. (1989). The expression of acetylated microtubules during axonal and dendritic growth in cerebellar macroneurons which develop in vitro. Dev. Brain Res. 49, 205-213.
74. Flament, S., Delacourte, A., Hemon, B., and Defossez, A. (1989). Characterization of two pathological tau-protein variants in Alzheimer brain cortices. J. Neural. Sei. 92, 133-141.
75. Flament, S., Delacourte, A., and Mann, D. M. A. (1990). Phosphorylation of Tau proteins: A major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res. 516,15-19.
76. Flament, S., Delacourte, A., Verny, M., Hauw, J. J., and Javoy-Agid F. (1991). Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Ada Neuropathol. 81, 591-596.
77. Fleming, L. M., and Johnson, G. V. M. (1995). Modulation of the phosphorylation state of Tau in situ: The roles of calcium and cyclic AMP. Biochem. J. 309, 41-47.
78. Garruto, R. M. (1991). Pacific paradigms of environmentally-induced neurological disorders: Clinical, epidemiological and molecular perspectives. Neurotoxicology 12, 347-378.
79. Carver, T. D., Harris, K. A., Lehman, R. A. \V., Lee, V. M. Y., Trojanowski, J. Q., and Billingsley, M. L. (1994). Tau phosphorylation in human, primate, and rat brain: Evidence that a pool of Tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J. Neurochem. 63. 2279-2287.
80. Garver, T. D., Lehman, R. A. W., and Billingsley, M. L. (1996). Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau. J. Neiirosci. Res. 44, 12-20.
81. Georgieff, I. S., Liem, R. K. H., Couchie, D., Mavilia, C, Nunez, J., and Shelanski, M. (1993). Expression of high molecular weight Tau in the central and peripheral nervous systems. J. Cell Sei. 105, 729-737.
82. Gerstmann, J., Sträussler, E., and Schienker, I. (1936). Uber eigernartige hereditar-familiare Erkrankung des Zentralnervensystems. Z. Neural. 154, 736-762.
83. Ghetti, B., Dlouhy, S. R., Giaccone, G., Bugiani, O., Frangione, B., Farlow, M. R., and Tagliavini, F. (1995). Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol. 5, 61-75.
84. Ghetti, B., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C, Frangione, B., Bugiani, O., Giaccone, G., Prelli, F., Goedert, M., Dlouhy, S. R., and Tagliavini, F. (1996). Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sei. USA 93, 744-748.
85. Giaccone, G., Pedrotti, B., Migheli, A., Verga, L., Perez, J., Racagni, G., Smith, M. A., Perry, G., Degioia, L., Selvaggini, C., Salmona, M., Ghiso, J., Frangione, B., Islam, K., Bugiani, O., and Tagliavini, F. (1996). beta PP and Tau interaction: A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 148, 79-87.
86. Giannakopoulos, P., Hof, P. R., Giannakopoulos, A. S., Herrmann, F. R., Michel, J. P., and Bouras, C. (1995a). Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch. Neural. 52, 1150-1159.
87. Giannakopoulos, P., Hof, P. R., and Bouras, C. (1995b). Age versus ageing as a cause of dementia. Lancet 346, 1486-1487.
88. Goedert, M., and Jakes, R. (1990). Expression of separate isoforms of human Tau protein: Correlation with the Tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225-4230.
89. Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., and Crowther, R. A. (1989a). Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing 4 tandem repeats-Differential expression of tau protein messenger RNAs in human brain. EMBO J. 8, 393-399.
90. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., and Crowther, R. A. (19895). Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
91. Goedert, M., Spillantini, M. G., Cairns, N. J., and Crowther, R. A. (1992). Tau-proteins of Alzheimer paired helical filaments-Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
92. Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., and Cras, P. (1994). Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in Tau protein. Biochem. J. 301, 871-877.
93. Goedert, M., Jakes, R., and Vanmechelen, E. (1995). Monoclonal antibody AT8 recognizes Tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189,167-170.
94. Gong, C. X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1995). Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J. Neurocliem. 65, 732-738.
95. Goode, B. L., and Feinstein, S. C. (1994). Identification of a novel microtubule binding and assembly domain in the developmentally regulated Inter-Repeat region of tau. J. Cell Biol. 124, 769-782.
96. Goto, S., Yamamoto, H., Fukunaga, K., Iwasa, T., Matsukado, Y., and Miyamoto, E. (1985). Dephosphorylation of microtubule-associated protein 2, Tau factor, and tubulin by calcineurin. J. Neurochem. 451, 276-283.
97. Gotz, J., Probst, A., Spillantini, M. G., Schafer, T., Jakes, R., Burki, K., and Goedert, M. (1995). Somatodendritic localization and hyperphosphorylation of Tau protein in transgenic mice expressing the longest human brain Tau isoform. EMBO J. 14,1304-1313.
98. Greenberg, S. G., Davies, P. Schein, J. D., and Binder, L. I. (1992). Hydrofluoric acid-treated tau-PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569.
99. Greenwood, J. A., and Johnson, G. V. W. (1995). Localization and in situ phosphorylation state of nuclear tau. Exp. Cell Res. 220, 332-337.
100. Greenwood, J. A., Scott, C. W., Spreen, R. C, Caputo, C. B., and Johnson, G. V. W. (1994). Casein kinase II preferentially phosphorylates human Tau isoforms containing an aminoterminal insert-Identification of threonine 39 as the primary phosphate acceptor. J. Biol. Chem. 269, 4373-4380.
101. Griffith, L. M., and Pollard, T. D. (1978). Evidence for actin filament-microtubule interaction mediated by microtubule-associated proteins. J. Cell Biol. 78, 958-965.
102. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., et al. (1986). Abnormal phosphorylation of the Map Tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sei. USA 83, 4913-4917.
103. Gustafson, L. (1993). Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 4, 143-148.
104. Gustke, N., Steiner, B., Mandelkow, E. M., Biernat, J., Meyer, H. E., and Goedert, M. (1992). The Alzheimer-like phosphorylation of tau-protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEES Lett. 307, 199-205.
105. Gustke, N., Trinczek, B., Mandelkow, E. M., and Mandelkow, E. (1994). Domains of Tau protein and interactions with microtubules. Biochemistry 33, 9511-9522.
106. Hagestedt, G., Lichtenberg, B., Wille, H., Mandelkow, E. M., and Mandelkow, M. (1989). Tau protein becomes long and stiff upon phosphorylation: Correlation between paracrystalline structure and degree of phosphorylation. J. Cell Biol. 109, 1643-1651.
107. Hakim, A. M., and Mathieson, G. (1979). Dementia in Parkinson's disease: A neuropathologic study. Neurology 29, 1204-1214.
108. Haltiwanger, R. S., Kelly, W. G., and Roquemore, E. P., Blomberg, M. A., Dong, D. L. Y., Kreppel, L., Chou, T. Y., and Hart, G. W. (1992). Glycosylation of nuclear and cytoplasmic proteins is ubiquitinous and dynamic. Biochem. Soc. Trans. 20, 264-269.
109. Hamre, K. M., Hyman, B. T., Goodlett, C. R., West, J. R., and Vanhoesen, G. W. (1989). Alz-50 Immunoreactivity in the neonatal rat - Changes in development and co-distribution with Map-2 immunoreactivity. Neurosd. Lett. 98, 264-271.
110. Hanger, O.P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. (1992). Glycogen synthase kinase-3 induces alzheimers disease-like phosphorylation of Tau-generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
111. Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Ohshima, T., Satoyoshitake, R., Takei, Y., Noda, T., and Hirokawa, N. (1994). Altered microtubule organization in small-calibre axons of mice lacking Tau protein. Nature 369, 488-491.
112. Hardy, J. (1992). An anatomical cascade hypothesis for Alzheimer's disease. Trends Neurosci. 15, 200-201.
113. Harper, P. S. (1989). "Myotonie Dystrophy," 2nd ed. Saunders, London.
114. Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., and Ihara, Y. (1992). Protein sequence and mass spectrometric analyses of Tau in the Alzheimer's disease brain. J. Biol. Chem. 267, 17047-17054.
115. Hasegawa, M., Watanabe, A., Takio, K., Suzuki, M., Arai, T., Titani, K., and Ihara, Y. (1993). Characterization of 2 distinct monoclonal antibodies to paired helical filaments-Further evidence for fetal-type phosphorylation of the Tau in paired helical filaments. J. Neurochem. 60,2068-2077.
116. Hasegawa, M., Jakes, R., Crowther, R. A., Lee, V. M. Y., Ihara, Y., and Goedert, M. (1996). Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against Tau protein. FEES Lett. 384, 25-30.
117. Hauw, J. J., Verny, M., Delaere, P., Cervera, P., He, Y., and Duyckaerts, C. (1990). Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy-Basic differences with Alzheimer's disease and aging. Neurosci. Lett. 119, 182-186.
118. Hauw, J. J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., Mckee, A., Tabaton, M., and Litvan, I. (1994). Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015-2019.
119. Henriquez, J. P., Cross, D., Vial, C, and Maccioni, R. B. (1995). Subpopulations of Tau interact with microtubules and actin filaments in various cell types. Cell Biochem. Fund. 13, 239-250.
120. Higgins, L. S. Rodems, J. M., Catalano, R., Quon, D., and Cordell, B. (1995). Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc. Natl. Acad. Sei. USA 92, 4402-4406.
121. Himmler, A. (1989). Structure of the bovine tau-gene-Alternatively spliced transcripts generate a protein family. Mol. Cell Biol. 9, 1389-1396.
122. Hirano, A., Kurland, L. T., Krooth, R. S., and Lessel, S. (1961). Parkinsonism-dementia complex, and endemic disease on the island of Guam: I. Clinical features. Brain 84,642-661.
123. Hirano, A., Dembitzer, H. M., and Kurland, L. Y. (1968). The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and Parkinson's dementia complex. J. Neuropathol. Exp. Neural. 67, 167-182.
124. Hirokawa, N., Shiomura, Y., and Okabe, S. (1988). Tau proteins: The molecular structure and mode of binding on microtubules. J. Cell Biol. 107, 1449-1459.
125. Hirokawa, N., Funakoshi, T., Satoharada, R., and Kanai, Y. (1996). Selective stabilization of Tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons. J. Cell Biol. 132,667-679.
126. Hof, P. R., and Morrison, J. H. (1994). The cellular basis of cortical disconnection in Alzheimer's disease and related dementing conditions. In "Alzheimer's Disease" (R. D. Terry, R. Katzman, and K. L. Bick, Eds.), pp. 197-229. Raven Press, New York.
127. Hof, P. R., Perl, D. P., Loerzel, A. J., and Morrison, J. H. (1991). Neurofibrillary tangle distribution in the cerebral cortex of Parkinsonism-dementia cases from Guam - Differences with Alzheimer's disease. Brain Res. 564, 306-313.
128. Hof, P. R., Bouras, C, Buée, L., Delacourte, A., Perl, D. P., and Morrison, J. H. (1992a). Differential distribution of neurofibrillary tangles in the cerebral cortex of Dementia Pugilistica and Alzheimer's disease cases. Acta Neuropathol. 85, 23-30.
129. Hof, P. R., Delacourte, A., and Bouras, C. (1992b). Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy. A quantitative analysis of 6 cases. Acta Neuropathol. 84, 45-51.
130. Hof, P. R., Nimchinsky, E. A., Buée-Scherrer, V., Buée L., Nasrallah, J., Hottinger, A. F., Purohit, D. P., Loerzel, A. J., Steele, J. C., Delacourte, A., Bouras, C, Morrison, J. H., and Perl, D. P. (1994a). Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: Quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol. 88, 397-404.
131. Hof, P. R., Bouras, C, Perl, D. P., and Morrison, J. H. (1994b). Quantitative neuropathologic analysis of picks disease cases - Cortical distribution of pick bodies and coexistence with alzheimers disease. Acta Neuropathol. 87,115-124.
132. Hof, P. R., Bouras, C., Perl, D. P., Sparks, D. L., Mehta, N., and Morrison, J. H. (1995). Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome: Quantitative regional analysis and comparison with Alzheimer's disease. Arch. Neural. 52, 379-391.
133. Huang, D. Y., Weisgraber, K. H., Goedert, M., Saunders, A. M., Roses, A. D., and Strittmatter, W. J. (1995). ApoE3 binding to Tau tandem repeat I is abolished by Tau serine(262) phosphorylation. Neurosci. Lett. 192, 209-212.
134. Hyman, B. T., Elvhage, T. E., and Reiter, J. (1994). Extracellular signal regulated kinases-Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Am. J. Pathol. 144, 565-572.
135. Ihara, Y., Nukina, N., Miura, R., and Ogawara, M. (1986). Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. (Tokyo) 99,1807-1810.
136. Ikeda, K., Akiyama, H., Kondo, H., and Ikeda, K. (1993). Anti-tau-positive glial fibrillary tangles in the brain of postencephalitic parkinsonism of economo type. Neurosci. Lett. 162,176-178.
137. Ikeda, K., Akiyama, H., Kondo, H., Arai, T., Arai, N., and Yagishita, S. (1995). Numerous glial fibrillary tangles in oligondendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles. Neurosci. Lett. 194, 133-135.
138. Ingebristen, T. S., and Cohen, P. (1983). Protein phosphatases: Properties and role in cellular regulation. Science 221, 331-338.
139. Ingelson, M., and Lannfelt, L. (1996). Tau in fibroblasts with and without the Swedish APP 670/671 mutation. Neurobiol. Aging 17 (Suppl. 4), S101.
140. Iqbal, K., and Grundke-Iqbal, I. (1995). Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau abd causes the disruption of microtubules. Neurobiol. Aging 16, 375-379.
141. Ishii, T., and Nakamura, Y. (1981). Distribution and ultrastructure of Alzheimer's neurofibrillary tangles in postencephalitic Parkinsonism of Economo type. Acta Neuropathol. 55,59-62.
142. Jaspert, A., Fahsold, R., Grehl, H., and Claus, D. (1995). Myotonie dystrophy: Correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J. Neural. 242, 99-104.
143. Joachim, C. L., Morris, J. H., Kosik, K. S., and Selkoe, D. J. (1987). Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Ann. Neural. 22,514-520.
144. Johnson, G. V. W. (1992). Differential phosphorylation of Tau by cyclic AMP-dependent protein kinase and Ca-2+/calmodulin-dependent protein kinase-II - Metabolic and functional consequences. J. Neurochem. 59, 2056-2062.
145. Kanai, Y., Takemura, R., Oshima, T., Mori, H., Ihara, Y., Yanagisawa, M., Masaki, T., and Hirokawa, N. (1989). Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J. Cell Biol. 109, 1173-1184.
146. Kanai, J., Chen, J., and Hirokawa, N. (1992). Microtubule bundling by Tau proteins in vivo: Analysis of functional domains. EMBO J. 11, 3953-3961.
147. Kidd, M. (1963). Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
148. Kiuchi, A., Otsuka, N., Namba, Y., Nakano, I., and Tomonaga, M. (1991). Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol. 82, 1-5.
149. Knops, J., Kosik, K. S., Lee, G., Pardee, J. D., Cohengould, L., and Mcconlogue, L. (1991). Overexpression of tau in a nonneuronal cell induces long cellular processes. J. Cell Biol. 114, 725-733.
150. Korneyev, A., Binder, L., and Bernardis, J. (1995). Rapid reversible phosphorylation of rat brain Tau proteins in response to cold water stress. Neurosci. Lett. 191, 19-22.
151. Kosik, K. S., Orecchio, L. D., Bakalis, S., and Neve, R. L. (1989). Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
152. Ksiezak-Reding, H., Morgan, K., Mattiace, L. A., Davies, P., Liu, W. K., Yen, S. H., Weidenheim, K., and Dickson, D. W. (1994). Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am. J. Pathol. 145, 1496-1508.
153. Ledesma, M. D., Bonay, P., Colaco, C, and Avila, J. (1994). Analysis of microtubule-associated protein Tau glycation in paired helical filaments. J. Biol. Chem. 269,21614-21619.
154. Ledesma, M. D., Bonay, P., and Avila, J. (1995). Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J. Neurochem. 65, 1658-1664.
155. Lee, G., and Rook, S. L. (1992). Expression of tau protein in non-neuronal cells-Microtubule binding and stabilization. J. Cell Sei. 102, 227-237.
156. Lee, G., Cowan, N., and Kirschner, M. (1988). The primary structure and heterogeneity of Tau protein from mouse brain. Science 239, 285-289.
157. Lee, G., Neve, R. L., and Kosik, K. S. (1989). The microtubule binding domain of tau protein. Neuron 2,1615-1624.
158. Lenders, M. B., Peers, M. C., Tramu, G., Delacourte, A., Defossez, A., Petit, H., and Mazzuca, M. (1989). Dystrophie peptidergic neuntes in senile plaques of Alzheimers disease hippocampus precede formation of paired helical filaments. Brain Res. 481, 344-349.
159. Leterrier, J. F., Liem, R. K., and Shelanski, M. L. (1982). Interactions between neurofilaments and microtubule-associated proteins: A possible mechanism for intraorganellar bridging. J. Cell Biol. 95, 982-986.
160. Lindwall, G., and Cole, R. D. (1984). Phosphorylation affects the ability of Tau protein to promote microtubule assembly. J. Biol. Chem. 255, 5301-5305.
161. Litersky, J. M., and Johnson, G. V. W. (1992). Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267, 1563-1568.
162. Liu, W. K., Williams, R. T., Hall, F. L., Dickson, D. W., and Yen, S. H. (1995). Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am. J. Pathol. 146, 228-238.
163. Lobert, S., Isern, N., Hennington, B. S., and Correia, J. J. (1994). Interaction of tubulin and microtubule proteins with vanadate oligomers. Biochemistry 33, 6244-6252.
164. Lopresti, P. Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., and Binder, L. I. (1995). Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes. Proc. Natl. Acad. Sei. USA 92, 10369-10373.
165. Love, S., Bridges, L. R., and Case, C. P. (1995). Neurofibrillary tangles in Niemann-Pick disease type C. Brain 118,119-129.
166. Malandrini, A., Cavallaro, T., Fabrizi, G. M., Berti, G., Salvestroni, R., Salvadori, C., and Guazzi, G. C. (1995). Ultrastructure and immunoreactivity of dystrophic axons indicate a different pathogenesis of Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Virchows Archiv. A 427, 415-421.
167. Mandelkow, E., and Mandelkow, E. M. (1994). Microtubule structure. Curr. Opin. Struct. Biol 4,171-179.
168. Mandell, J. W., and Banker, G. A. (1995). The rnicrotubule cytoskeleton and the development of neuronal polarity. Neuwbiol. Aging 16,229-237.
169. Mann, D. M. A., Prinja, D., Davies, C. A., Ihara, Y., Delacourte, A., Defossez, A., Mayer, R. J., and Landon, M. (1989). Immunocytochemical profile of neurofibrillary tangles in Downs syndrome patients of different ages. J. Neural. Sei. 92, 247-260.
170. Martin, H., Lambert, M. P., Barber, K., Hinton, S., and Klein, W. L. (1995). Alzheimer's-associated phospho-Tau epitope in human neuroblastoma cell cultures: Up-regulation by fibronectin and laminin. Neuroscience 66, 769-779.
171. Marya, P. K., Syed, Z., Fraylich, P. E., and Eagles, P. A. M. (1994). Kinesin and Tau bind to distinct sites on microtubules. J. Cell Sei. 107, 339-344.
172. Matsuo, E. S., Shin, R. W., Billingsley, M. L., Vandevoorde, A., O'connor, M., Trojanowski, J. Q., and Lee, V. M. Y. (1994). Biopsy-derived adult human brain Tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13,989-1002.
173. Matus, A. (1994). Stiff microtubules and neuronal morphology. Trends Neurosci. 17,19-22.
174. Mawal-Dewan, M., Henley, J., Vandevoorde, A., Trojanowski, J. Q., and Lee, V. M. Y. (1994). The phosphorylation state of Tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269, 30981-30987.
175. McKhann, G. M., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease. Neurology 34, 939-944.
176. McQuaid, S., Alien, I. V., Mcmahon, J., and Kirk, J. (1994). Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis - A combined in situ hybridization and immunocytochemical investigation. Neuropathol. Appl. Neural. 20, 103-110.
177. Mercer, J. A., Albanesi, J. P., and Brady, S. T. (1994). Molecular motors and cell motility in the brain. Brain Pathol. 4, 167-179.
178. Mercken, M., Vandermeeren, M., Lubke, U., Six, J., Boons, J., and Vandevoorde, A. (1992). Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. 84,265-272.
179. Mercken, M. Fischer, I., Kosik, K. S., and Nixon, R. A. (1995). Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: Evidence for dynamic interactions of Tau with microtubules in vivo. J. Neurosci. 15, 8259-8267.
180. Merrick, S. E., Demoise, D. C., and Lee, V. M. Y. (1996). Site-specific dephosphorylation of tau protein at Ser(202)/Thr(205) in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J. Biol. Chem. 271, 5589-5594.
181. Michalik, L., Neuville, P., Vanier, M. T., and Launay, J. F. (1995). Pancreatic Tau related maps: Biochemical and immunofluorescence analysis in a tumoral cell line. Mol. Cell Biochem. 143, 107-112.
182. Mitake, S., Inagaki, T., Niimi, T., Shirai, T., Yamamoto, M. (1989). Development of Alzheimer neurofibrillary changes in two autopsy cases of myotonic dystrophy. Clin. Neurol. (Tokyo) 29, 488-492.
183. Montpetit, V., Clapin, D. F., and Guberman, A. (1985). Substructure of 20-nm filaments of progressive supranuclear palsy. Acta Neuropathol. 68, 311-318.
184. Mori, H., Kondo, J., and Ihara, Y. (1987). Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644.
185. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K., and Ihara, Y. (1993). Ubiquitin is conjugated with amino-terminally processed Tau in paired helical filaments. Neuron 10, 1151-1160.
186. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., and Ihara, Y. (1995). Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823-829.
187. Mukaeto-Valadinska, E., Harrington, C. R., Roth, M., and Wischik, C. M. (1996). Alterations in Tau protein metabolism during normal aging. Dementia 7, 95-103.
188. Murakami, N., Ishiguro, K., Ihara, Y., Nonaka, L, Sugita, H., and Imahori, K. (1995). Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers. Acta Neuropalhol. 90, 467-471.
189. Nelson, P. T., and Safer, C. B. (1995). Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol. Aging. 16, 315-323.
190. Neuville, P., Vanier, M. T., Michalik, L., and Launay, J. F. (1995). In situ localization with digoxigenin-labelled probes of tau-related mRNAs in the rat pancreas. Histochem. J. 27, 565-574.
191. Neve, R. L., Harris, P., Kosik, K., Kurnit, D. M., and Donlon, A. (1986). Identification of cDNA clones for the human microtubule-associated protein Tau and chromosmal location of genes for Tau and microtubule-associated protein 2. Mol Brain Res I, 271-280.
192. Nieto, A., Correas, I., Lopezotin, C, and Avila, J. (1991). Tau-related protein present in paired helical filaments has a decreased tubulin binding capacity as compared with microtubule-associated protein tau. Biochim. Biophys. Acta 1096, 197-204.
193. Nishimura, M., Tomimoto, H., Suenaga, T., Namba, Y., Ikeda, K., Akiguchi, I., and Kimura, J. (1995). Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am. J. Pathol. 146,1052-1058.
194. Nishiyama, I., Oota, T., and Ogiso, M. (1995). Expression of tau-like microtubule-associated proteins in calcitonin-producing cells. Biomed. Res. 16, 59-62.
195. Ono, S., Inoue, K., Mannen, T., Kanda, F., Jinnai, K., and Takahashi, K. (1987). Neuropathological changes of the brain in myotonic dystrophy. Some new observations. J. Neural. Sei. 81, 301-320.
196. Ono, T., Yamamoto, H., Tashima, K., Nakashima, H., Okumura, E., Yamada, K., Hisanaga, S. I., Kishimoto, T., Miyakawa, T., and Miyamoto, E. (1995). Dephosphorylation of abnormal sites of Tau factor by protein phosphatases and its implication for Alzheimer's disease. Neurochem. Int. 26, 205-215.
197. Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., and Lee, V. M. Y. (1994). Monoclonal antibody PHF-1 recognizes Tau protein phosphorylated at serine residues 396 and 404. J. Neurosd. Res. 39, 669-673.
198. Oyama, F., Gu, Y., Murakami, N., Nonaka, I., and Ihara, Y. (1996). Nonneuronal tau, transient upregulation and subsequent accumulation of big Tau and small Tau in chloroquine neuropathy. Neurobiol. Aging 17(Suppl. 4), S188. [Abstract 759]
199. Oyanagi, K., Makifushi, T., Ohtoh, T., Ikuta, F., Chen, K. M., Chase, T. N., and Gajdusek, D. C. (1994). Topographic investigation of brain atrophy in Parkinsonism dementia complex of Guam: A comparison with Alzheimer's disease and progressive supranuclear palsy. Neurodegeneration 3, 301-304.
200. Panda, D., Goode, B. L., Feinstein, S. C., and Wilson, L. (1995). Kinetic stabilization of microtubule dynamics at steady state by Tau and microtubule-binding domains of tau. Biochemistry 34, 11117-11127.
201. Papasozomenos, S. C. (1996). Heat shock induces rapid dephosphorylation of Tau in both female and male rats followed by hyperphosphorylation only in female rats: Implications for Alzheimer's disease. J. Neurochem. 66,1140-1149.
202. Parent, M., Delacourte, A., Défossez, A., Hémon, B., Han, K-K., and Petit, H. (1988). Alzheimer's disease: Study of the distribution of paired helical filaments tau proteins in the human central nervous system. C. R. Acad. Sei. 306, 391-397.
203. Paulus, W., and Selim, M. (1990). Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol. 81, 89-94.
204. Pillon, B., Gouiderkhouja, N., Deweer, B., Vidailhet, M., Malapani, C, Dubois, B., and Agid, Y. (1995). Neuropsychological pattern of striatonigral degeneration: Comparison with Parkinson's disease and progressive supranuclear palsy. J. Neural. Neurosurg. Ps. 58,174-179.
205. Pizzi, M., Valerio, A., Arrighi, V., Galli, P., Belloni, M., Ribola, M., Alberici, A., Spano, P., and Memo, M. (1995). Inhibition of glutamate-induced neurotoxicity by a Tau antisense oligonucleotide in primary culture of rat cerebellar granule cells. Eur. Neurosci. 7,1603-1613.
206. Poirier, J., Minnich, A., and Davignon, J. (1995). Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann. Med. 27, 663-670.
207. Pollard, T. D. (1983). Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments. J. Biol. Chem. 258, 7064-7067.
208. Pope, W., Enam, S. A., Bawa, N., Miller, B. E., Ghanbari, H. A., and Klein, W. L. (1993). Phosphorylated Tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system. Exp. Neural. 120, 106-113.
209. Praprotnik, D., Smith, M. A., Richey, P. L., Vinters, H. V., and Perry, G. (1996). Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol. 91, 226-235.
210. Rebhan, M., Vacun, G., and Rosner, H. (1995). Complementary distribution of Tau proteins in different phosphorylation states within growing axons. Neuroreport 6, 429-432.
211. Rendeon, A. D., Jung, D., and Jancsik, V. (1990). Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria. Biochem. J. 269, 555-556.
212. Reszka, A. A., Seger, R., Diltz, C. D., Krebs, E. G., and Fischer, E. H. (1995). Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sei. USA 92, 8881-8885.
213. Rewcastle, N. B. (1991). Degenerative diseases of the central nervous system. In "Textbook of Neuropathology, second edition" (R. L. Davis and D. M. Robertson, Eds.), pp. 903-961. Williams & Wilkins, Baltimore.
214. Riederer, B. M., and Binder, L. I. (1994). Differential distribution of Tau proteins in developing cat cerebellum. Brain Res. Bull. 33, 155-161.
215. Rinne, J. O., Lee, M. S., Thompson, P. D., and Marsden, C. D. (1994). Corticobasal degeneration: A clinical study of 36 cases. Brain 117,1183-1196.
216. Rosner, H., Rebhan, M., Vacun, G., and Vanmechelen, E. (1995). Developmental expression of Tau proteins in the chicken and rat brain: Rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult Tau isoforms. Int. J. Dev. Neurosci. 13, 607-617.
217. Sadot, E., Heicklenklein, A., Barg, J., Behar, L., Ginzburg, I., and Fisher, A. (1996a). Identification of a Tau promoter region mediating tissue-specific-regulated expression in PC12 cells. J. Mol. Biol. 256, 805-812.
218. Sadot, E., Gunvitz, D. B., Lazarovici, P., and Ginzburg, I. (1996b). Activation of m(1) muscarinic acetylcholine receptor regulates Tau phosphorylation in transfected PC12 cells. J. Neurochem. 66, 877-880.
219. Saito, T., Ishiguro, K., Uchida, T., Miyamoto, E., Kishimoto, T., and Hisanaga, S. (1995). In situ dephosphorylation of Tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEES Lett. 376, 238-242.
220. Saoudi, Y., Paintrand, I., Multigner, L., and Job, D. (1995). Stabilization and bundling of subtilisin-treated microtubules induced by microtubule associated proteins. J. Cell Sci. 108, 357-367.
221. Sattilaro, R. F., Dentier, W. L.; and LeChuyse, E. L. (1981). Microtubule-associated proteins (MAPs) and the organization of actin filaments in vitro. J. Cell Biol. 90, 467-473.
222. Sautière, P. E., Caillet-Boudin, M. L., Wattez, A., and Delacourte, A. (1994). Detection of Alzheimer-type Tau proteins in okadaic acid-treated Sknsh-Sy 5Y neuroblastoma cells. Neurodegeneration 3, 53-60.
223. Sawa, A., Oyama, F., Matsushita, M., et al. (1994). Molecular diversity at the carboxyl terminus of human and rat Tau. Mol. Brain Res. 27, 111-117.
224. Schmidt, M. L., Didario, A. G., Lee, V. M. Y., and Trojanowski, J. Q. (1994). Extensive network of PHF tau-rich dystrophic neuntes permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 344, 69-73.
225. Schmidt, M. L. Huang, R., Martin, J. A., Henley, J., Mawal-Dewan, M., Hurtig, H. I., Lee, V. M. Y., and Trojanowski, J. Q. (1996a). Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J. Neuropathol. Exp.-Neurol. 55, 534-539.
226. Schmidt, M. L., Huang, R., Martin, J. A., Henley, J., Mawal-Dewan, M., Hurtig, H. L, Lee, V. M. Y., and Trojanowski, J. Q. (1996b). Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J. Neuropathol. Exp. Neural. 55, 534-539.
227. Schoenfeld, T. A., and Obar, R. A. (1994). Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. Int. Rev. Cytol. 151, 67-137.
228. Schweers, O., Mandelkow, E. M., Biernat, J., and Mandelkow, E. (1995). Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein Tau controls the in vitro assembly of paired helical filaments. Proc. Nail. Acad. Sei USA 92, 8463-8467.
229. Sergeant, N., Bussiere, T., Vermersch, P.., Lejeune, J. P., and Delacourte, A. (1995). Isoelectric point differentiates PHF-Tau from biopsy-derived human brain Tau proteins. Neuroreport 6, 2217-2220.
230. Seubert, P., Mawaldewan, M., Barbour, R., Jakes, R., Goedert, M., Johnson, G. V. W., Litersky, J. M., Schenk, D., Lieberburg, L, Trojanowski, J. Q., and Lee, V. M. Y. (1995). Detection of phosphorylated Ser(262) in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270, 18917-18922.
231. Shackelford, D. A., and Nelson, K. E. (1996). Changes in phosphorylation of Tau during ischemia and reperfusion in the rabbit spinal cord. J. Neurochem. 66, 286-295.
232. Shankar, S. K., Yanagihara, R. M., Garruto, I., Grundke-Iqbal, K. S., Kosik, D. C, and Gajdusek, C. (1989). Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and Parkinsonism-Dementia of Guam. Ann. Neural. 25, 146-151.
233. Shea, T. B., and Fischer, I. (1996). Phosphatase inhibition in human neuroblastoma cells alters Tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 380, 63-67.
234. Shea, T. B., Beermann, M. L., Nixon, R. A., and Fischer, I. (1992). Microtubule-associated protein tau is required for axonal neurite elaboration by neuroblastoma cells. J. Neurosci. Res. 32, 363-374.
235. Shinozaki, T., Watanabe, H., Arita, S., and Chigira, M. (1995). Amino acid phosphatase activity of alkaline phosphatase-A possible role of protein phosphatase. Eur. J. Biochem. 227, 367-371.
236. Singh, T. J., Zaidi, T., Grundke-Iqbal., and Iqbal, K. (1996). Non-proline-dependent protein kinases phosphorylate several sites found in Tau from Alzheimer disease brain. Mol. Cell. Biochem. 154, 143-151.
237. Smith, M. A., Siedlak, S. L., Richey, P. L., Mulvihill, P., Ghiso, J., Frangione, B., Tagliavini, F., Giaccone, G., Bugiani, O., Praprotnik, D., Kalaria, R. N., and Perry, G. (1995a). Tau protein directly interacts with the amyloid beta-protein precursor: Implications for Alzheimer's disease. Nature Med. I, 365-369.
238. Smith, M. A., Sayre, L. M., Monnier, V. M., and Perry, G. (1995b). Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
239. Song, J. S., and Yang, S. D. (1995). Tau protein kinase I/GSK-3 beta/kinase F-A in heparin phosphorylates Tau on Ser(199), Thr(231), Ser(235), Ser(262) Ser(369), and Ser(400) sites phosphorylated in Alzheimer disease brain. J. Protein Client. 14, 95-105.
240. Sontag, E., Nunbhakdicraig, V., Bloom, G. S., and Mumby, M. C. (1995). A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128, 1131-1144.
241. Soulié, C, Lepagnol, J., Delacourte, A., and Caillet-Boudin M. L. (1996). Dephosphorylation studies of SKNSH-Sy 5Y cell Tau proteins by endogenous phosphatase activity. Neurosci. Lett. 206,189-192.
242. Sperber, B. R., Leight, S., Goedert, M., and Lee, V. M. Y. (1995). Glycogen synthase kinase-3 beta phosphorylates Tau protein at multiple sites in intact cells. Neurosd. Lett. 197,149-153.
243. Spillantini, M. G., Crowther, R. A., and Goedert, M. (1996). Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol. 92, 42-48.
244. Steele, J. C., Richardson, J. C., and Olzewski, J. (1964). Progressive supranuclear palsy. A heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neural. 10, 333-359.
245. Strittmatter, W. J., Saunders, A. M., Geodert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericakvance, M., Schmechel, D., and Roses, A. D. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sd. USA 91, 11183-11186.
246. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., and Imahori, K. (1996). Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of Tau protein kinase I glycogen synthase kinase-3 beta. Neurosd. Lett. 203, 33-36.
247. Takauchi, S., Hosomi, M., Marasigan, S., Sato, M., Hayashi, S., and Miyoshi, K. (1984). An ultrastructural study of Pick bodies. Acta Nettropathol. 644, 344-348.
248. Teller, J. K., Russo, C., Debusk, L. M., Angelini, G., Zaccheo, D., Dagnabricarelli, F., Scartezzini, P., Bertolini, S., Mann, D. M. A., Tabaton, M., and Gambetti, P. (1996). Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nature Med. 2, 93-95.
249. Tellez-Nagel, I., and Wisniewski, H. M. (1973). Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch. Neural. 29, 324-327.
250. Tomonaga, M. (1977). Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol. 37, 177-181.
251. Tranchant, C., Sergeant, N., Wattez, A., Mohr, M., Warter, J. M., and Delacourte, A. (1996). Biochemical study of the Tau protein in Gerstmann-Straussler-Scheinker syndrome with neurofibrillary tangles. Submitted for publication.
252. Turpin, J. C, Masson, M., and Baumann, N. (1991). Clinical aspects of Niemann-Pick type C disease in the adult. Dev. Neurosd. 13, 304-306.
253. Vandermeeren, M., Lubke, U., Six, J., and Cras, P. (1993). The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament Tau-Epitope in human LA-N-5 neuroblastoma cells. Neurosd. Lett. 153, 57-60.
254. Vermersch, P., Frigard, B., David, J. P., Fallet-Bianco, C., and Delacourte, A. (1992). Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged Non-Demented subjects. Neurosd. Lett. 144, 143-146.
255. Vermersch, P., Delacourte, A., Javoy-Agid, F., Hauw, J. J., and Agid, Y. (1993). Dementia in Parkinson's disease-Biochemical evidence for cortical involvement using the immunodetection of abnormal Tau-Proteins. Ann. Neural. 33, 445-450.
256. Vermersch, P., Robitaille, Y., Bernier, L., Wattez, A., Gauvreau, D., and Delacourte, A. (1994). Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement. Acta Neuropathol. 87, 572-577.
257. Vermersch, P., David, J. P., Frigard, B., Fallet-Bianco, C., Wattez, A., Petit, H., and Delacourte, A. (1995a). Cortical mapping of Alzheimer pathology in brains of aged nondemented subjects. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 19, 1035-1047.
258. Vermersch, P., Bordet, R., Ledoze, F., Ruchoux, M. M., Chapon, F., Thomas, P., Destée, A., and Lechevallier, B. (1995b). Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases. C. R. Acad. Sei. 318,439-445.
259. Vermersch, P., Sergeant, N., Ruchoux, M. M., Hofmann-Radvanyi, H., Petit, H., Dewailly, P., and Delacourte, A. (1996). Specific Tau variants in the brain from patients with myotonic dystrophy. Neurology 47, 711-717.
260. Vincent, I., Rosado, M., and Davies, P. (1996). Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132, 413-425.
261. Vulliet, R., Halloran, S. M., Braun, R. K., Smith, A. J., and Lee, G. (1992). Proline-directed phosphorylation of human Tau-protein. J. Biol. Chem. 267, 22570-22574.
262. Weingarten, M. D., Lockwood, A. H., Hwo, S-Y., and Kirschner, M. W. (1975). A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sei. USA 72, 1858-1862.
263. Wisniewski, T., Lalowski, M., Bobik, M., Russell, M., Strosznajder, J., and Frangione, B. (1996). Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques aged dogs. Biochem. J. 313, 575-580.
264. Yamada, T., McGeer, P. L., and McGeer, E. G. (1992). Appearance of paired nucleated, taupositive glia in progressive supranuclear palsy brain tissue. Neurosci. Lett. 135, 99-102.
265. Yamamoto, H., Saitoh, Y., Fukunaga, K., Nishimura, H., and Miyamoto, E. (1988). Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly. J. Neurochem. 50, 1614-1623.
266. Yamamoto, H., Hasegawa, M., Ono, T., Tashima, K., Ihara, Y., and Miyamoto, E. (1995). Dephosphorylation of fetal-Tau and paired helical filaments-Tau by protein phosphatases 1 and 2A and calcineurin. J. Biochem. 118, 1224-1231.
267. Yamazaki, M., Nakano, I., Imazu, O., Kaieda, R., and Terashi, A. (1995). Paired helical filaments and straight tubules in astrocytes: An electron microscopic study in dementia of the Alzheimer type. Acta Neuropathol. 90, 31-36.
268. Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., Zweiter, J. L., and Stern, D. (1995). Nonenzymatically glycated Tau in Alzheimer's disease induces neuronal ozidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nature Med. 1, 693-699.